Maria Isabel Leite Selected Research

Transverse Myelitis (Necrotizing Myelitis)

1/2022	Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.
11/2020	A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.
1/2020	Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.
10/2019	Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease.
9/2016	Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status.
11/2013	Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
7/2008	Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Isabel Leite Research Topics

Disease

21	Neuromyelitis Optica (Devic's Disease) 02/2022 - 07/2008
12	Myasthenia Gravis 01/2021 - 03/2005
9	Multiple Sclerosis 02/2022 - 07/2007
7	Transverse Myelitis (Necrotizing Myelitis) 01/2022 - 07/2008
6	Thymoma (Thymic Carcinoma) 02/2019 - 01/2008
4	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 02/2014
3	Ganglion Cysts (Ganglion) 11/2021 - 12/2018
3	Pain (Aches) 01/2020 - 09/2016
2	Relapsing-Remitting Multiple Sclerosis 04/2021 - 02/2017
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 10/2019 - 11/2013
2	Infections 02/2019 - 11/2014
1	Cognitive Dysfunction 01/2022
1	COVID-19 01/2021
1	Fatigue 01/2020
1	Herpes Genitalis (Genital Herpes) 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2019
1	Alopecia (Baldness) 02/2019
1	Chronic Hepatitis (Chronic Active Hepatitis) 02/2019
1	Candidiasis (Moniliasis) 02/2019
1	Lichen Planus (Lichen Ruber Planus) 02/2019
1	Exfoliative Dermatitis (Erythroderma) 02/2019
1	Cytomegalovirus Infections (Inclusion Disease) 02/2019
1	Thymus Hyperplasia 01/2019
1	Optic Nerve Diseases (Optic Neuropathy) 12/2018
1	Hyperandrogenism 01/2018
1	Morbid Obesity 01/2018
1	Hypothyroidism 01/2018
1	Neuralgia (Stump Neuralgia) 02/2017
1	Myelitis 02/2017
1	Diffuse Brain Injuries (Diffuse Brain Injury) 07/2015
1	Opportunistic Infections (Opportunistic Infection) 11/2014
1	Epilepsy (Aura) 08/2014
1	Glioma (Gliomas) 01/2013
1	Heart Failure 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Chronic Progressive Multiple Sclerosis 01/2013
1	Spasm (Spasms) 12/2011
1	Stiff-Person Syndrome (Stiff Man Syndrome) 12/2011
1	Progressive Encephalomyelitis with Rigidity 12/2011
1	Myoclonus (Nocturnal Myoclonus) 12/2011
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 02/2010
1	Chronic Mucocutaneous Candidiasis 02/2010
1	Disease Progression 07/2007
1	Autoimmune Diseases (Autoimmune Disease) 10/2005

Drug/Important Bio-Agent (IBA)

21	AntibodiesIBA 08/2021 - 03/2005
9	Cholinergic ReceptorsIBA 01/2019 - 03/2005
8	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021 - 11/2013
8	muskIBA 01/2021 - 03/2005
7	Retinaldehyde (Retinal)IBA 01/2022 - 11/2014
6	AutoantibodiesIBA 01/2020 - 01/2008
5	anti-aquaporin 4 autoantibodyIBA 01/2020 - 11/2013
5	Aquaporin 4IBA 01/2020 - 08/2010
4	Aquaporins (Water Channels)IBA 01/2020 - 02/2017
4	Phosphotransferases (Kinase)IBA 01/2018 - 03/2005
3	Immunoglobulin G (IgG)IBA 01/2022 - 07/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2005
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
2	Acid Sensing Ion ChannelsIBA 01/2019 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 11/2014
2	Amiloride (Midamor)FDA LinkGeneric 01/2019 - 01/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 07/2017 - 07/2007
2	Glycine Receptors (Glycine Receptor)IBA 08/2014 - 12/2011
2	AntigensIBA 02/2010 - 07/2008
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	SteroidsIBA 01/2022
1	Pharmaceutical PreparationsIBA 12/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 09/2016
1	Protons (Proton)IBA 07/2015
1	Azathioprine (Imuran)FDA LinkGeneric 08/2013
1	Methotrexate (Mexate)FDA LinkGeneric 08/2013
1	Leucine (L-Leucine)FDA Link 01/2013
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2013
1	DiureticsIBA 01/2013
1	PotassiumIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2012
1	InterferonsIBA 10/2012
1	Immunologic Factors (Immunomodulators)IBA 10/2012
1	glucose-mannose-glucoseIBA 08/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 08/2011
1	Interferon-betaIBA 08/2010
1	CytokinesIBA 02/2010
1	Interleukin-22 (IL-22)IBA 02/2010
1	Interleukin-17 (Interleukin 17)IBA 02/2010
1	N 30IBA 03/2005

Therapy/Procedure

2	Thymectomy 02/2019 - 01/2019
1	Immunotherapy 01/2013
1	Therapeutics 12/2011